Used as a chiral building block in the synthesis of pharmaceutical intermediates, particularly in the development of protease inhibitors and other bioactive molecules. Its fluorinated aromatic structure enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in solid-phase peptide synthesis due to the Fmoc protecting group, enabling mild deprotection conditions. The (R)-configuration ensures stereochemical control in asymmetric synthesis, making it valuable in creating enantiomerically pure compounds for medicinal chemistry research.